CHICAGO (Reuters) - A Roche blood test to screen fetuses for Down syndrome worked far better than standard prenatal screening tests in younger, low-risk women, U.S. researchers said on Wednesday, ...

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced the launch of Fetal Focus, a noninvasive prenatal ...

Some physicians and researchers argue that newer forms of non-invasive prenatal testing could become another tool in the effort to improve outcomes.

Researchers found that maternal plasma cell-free DNA methylation patterns in late pregnancy were associated with later autism ...

Add Yahoo as a preferred source to see more of our stories on Google. During a pregnancy, women are offered prenatal genetic screening and diagnostic testing to determine whether a fetus is healthy or ...

Noninvasive fetal genome sequencing (NIFS) detects over 95% of variants and could reduce reliance on amniocentesis and other ...

Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...

A team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT and Harvard have developed a non-invasive genetic test that can ...

NEW YORK (Reuters Health) - Normally, parents who want to know the sex of their baby before it's born find out through ultrasound done in the second trimester. A blood test that can be done early in ...

Cell-free fetal DNA fraction (FF) in maternal plasma is a key parameter affecting the performance of noninvasive prenatal testing (NIPT). Accurate quantitation of FF plays a pivotal role in these ...

Add Yahoo as a preferred source to see more of our stories on Google. These MRI images with arrows indicating cancer were made during a study by researchers at the National Institutes of Health and ...

Researchers have developed a non-invasive genetic test that can screen the blood of pregnant individuals to survey all genes from the fetal genome. A team of investigators from Massachusetts General ...